Contineum Therapeutics Inc News - CTNM | ADVFN

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

Home
Investing
Stocks
USA
NASDAQ
Contineum Therapeutics Inc (CTNM)
Contineum Therapeutics Inc (CTNM) News

Contineum Therapeutics Inc (CTNM)

14.41

0.27

(1.91%)

Closed December 25 4:00PM

Delayed by 15 minutes

14.41

0.00

(0.00%)

After Hours: 5:00PM

Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Contineum Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights

-Contineum is focused on leading the Neuroscience, Inflammation and Immunology (NI&I) field- -Successful completion of Initial Public...

Contineum Therapeutics Announces Pricing of Initial Public Offering

SAN DIEGO, April 04, 2024 (GLOBE NEWSWIRE) -- Contineum Therapeutics, Inc. (Contineum), a clinical stage biopharmaceutical company focused on...

1
2
3

Monksdream

Monksdream 3 months ago

CTNM still undecided

UpTickMeA$AP

UpTickMeA$AP 8 months ago

18,445,422 shares of Class A Common Stock outstanding

UpTickMeA$AP

UpTickMeA$AP 9 months ago

Johnson & Johnson

SHARED VOTING POWER 1,979,173

PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 10.7%

Percentage ownership is based on 18,445,422 shares of Class A Common Stock outstanding after the closing of the Issuer’s initial public offering on April 9, 2024, as provided to the Reporting Persons by the Issuer.

https://fintel.io/doc/sec-johnson-johnson-200406-sc-13g-2024-april-10-19823-6036

Contineum Therapeutics

Delayed Upgrade Clock